Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2011-04-21 | Mr. Ringo was Senior Vice President of Business Development, Strategy and Innovation at Pfizer Inc. and held various executive roles in biotechnology and pharmaceutical companies. |
| 2012-04-25 | He received a B.S. in Business Administration and an M.B.A. from the University of Dayton. Mr. Ringo’s extensive senior executive experience in both biotechnology and pharmaceutical companies provides valuable operational, commercial assessment and corporate leadership skills. |
| 2013-04-25 | Mr. Ringo’s extensive senior executive experience in both biotechnology and pharmaceutical companies provides valuable operational, commercial assessment and corporate leadership skills to the Board. |
| 2014-03-11 | He received a B.S. in business administration and an M.B.A. from the University of Dayton. Mr. Ringo's extensive senior executive experience in both biotechnology and pharmaceutical companies provides valuable operational, commercial assessment, corporate leadership and management skills to the Board. |
| 2015-04-28 | Mr. Ringo’s extensive senior executive experience in both biotechnology and pharmaceutical companies provides valuable operational, commercial assessment, corporate leadership and management skills to the Board. |
| 2016-04-25 | Mr. Ringo’s extensive senior executive experience in biotechnology and pharmaceutical companies. |
| 2017-04-25 | Mr. Ringo was Senior Vice President of Business Development, Strategy and Innovation at Pfizer Inc. and held various senior positions in biotechnology and pharmaceutical companies. |
Data sourced from SEC filings. Last updated: 2025-10-11